How Can We Improve the Assessment of Safety in Child and Adolescent Psychopharmacology?
- 1 June 2003
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 42 (6) , 634-641
- https://doi.org/10.1097/01.chi.0000046840.90931.36
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Early Methylphenidate Administration to Young Rats Causes a Persistent Reduction in the Density of Striatal Dopamine TransportersJournal of Child and Adolescent Psychopharmacology, 2001
- Pediatric PsychopharmacologyJournal of Child Psychology and Psychiatry, 2001
- Stimulant Treatment in Young Boys with Symptoms Suggesting Childhood Mania: A Report from a Longitudinal StudyJournal of Child and Adolescent Psychopharmacology, 2000
- A Retrospective Evaluation of a Data Mining Approach to Aid Finding New Adverse Drug Reaction Signals in the WHO International DatabaseDrug Safety, 2000
- Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young womenAmerican Journal of Obstetrics and Gynecology, 1999
- The Medical Dictionary for Regulatory Activities (MedDRA)Drug Safety, 1999
- Prescription-Event Monitoring of 10 895 Patients Treated with AlprazolamThe British Journal of Psychiatry, 1991
- Phenobarbital for Febrile Seizures — Effects on Intelligence and on Seizure RecurrenceNew England Journal of Medicine, 1990
- Valproic acid hepatic fatalitiesNeurology, 1987
- Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton.BMJ, 1981